Literature DB >> 19818302

Epidemiology and natural history of non-alcoholic steatohepatitis.

Curtis K Argo1, Stephen H Caldwell.   

Abstract

Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver condition in many parts of the world. This article describes the epidemiology and natural history of this disorder. It also describes current diagnostic and treatment methods and describes future implications NAFLD may have.

Entities:  

Mesh:

Year:  2009        PMID: 19818302     DOI: 10.1016/j.cld.2009.07.005

Source DB:  PubMed          Journal:  Clin Liver Dis        ISSN: 1089-3261            Impact factor:   6.126


  138 in total

1.  Role of ceramides in nonalcoholic fatty liver disease.

Authors:  Mangesh Pagadala; Takhar Kasumov; Arthur J McCullough; Nizar N Zein; John P Kirwan
Journal:  Trends Endocrinol Metab       Date:  2012-05-17       Impact factor: 12.015

2.  Nonalcoholic fatty liver disease: liver disease: an overlooked complication of diabetes mellitus.

Authors:  Marco Arrese
Journal:  Nat Rev Endocrinol       Date:  2010-12       Impact factor: 43.330

Review 3.  Histopathology of nonalcoholic fatty liver disease.

Authors:  Elizabeth M Brunt; Dina G Tiniakos
Journal:  World J Gastroenterol       Date:  2010-11-14       Impact factor: 5.742

Review 4.  Epidemiology of NAFLD and Type 2 Diabetes: Health Disparities Among Persons of Hispanic Origin.

Authors:  Mariana Lazo; Usama Bilal; Rafael Perez-Escamilla
Journal:  Curr Diab Rep       Date:  2015-12       Impact factor: 4.810

Review 5.  Inflammation and fibrogenesis in steatohepatitis.

Authors:  Hideki Fujii; Norifumi Kawada
Journal:  J Gastroenterol       Date:  2012-02-07       Impact factor: 7.527

Review 6.  Fatty liver in childhood.

Authors:  Yesim Ozturk; Ozlem Bekem Soylu
Journal:  World J Hepatol       Date:  2014-01-27

7.  Centrilobular ductular reaction correlates with fibrosis stage and fibrosis progression in non-alcoholic steatohepatitis.

Authors:  Lei Zhao; Maria Westerhoff; Rish K Pai; Won-Tak Choi; Zu-Hua Gao; John Hart
Journal:  Mod Pathol       Date:  2017-09-01       Impact factor: 7.842

8.  The effect of miRNA-122 in regulating fat deposition in a cell line model.

Authors:  Yu-Qiang Nie; Jie Cao; Yong-Jian Zhou; Xia Liang; Yan-Lei Du; Yu-Jui Yvonne Wan; Yu-Yuan Li
Journal:  J Cell Biochem       Date:  2014-05       Impact factor: 4.429

9.  SIRT7 represses Myc activity to suppress ER stress and prevent fatty liver disease.

Authors:  Jiyung Shin; Ming He; Yufei Liu; Silvana Paredes; Lidia Villanova; Katharine Brown; Xiaolei Qiu; Noushin Nabavi; Mary Mohrin; Kathleen Wojnoonski; Patrick Li; Hwei-Ling Cheng; Andrew J Murphy; David M Valenzuela; Hanzhi Luo; Pankaj Kapahi; Ronald Krauss; Raul Mostoslavsky; George D Yancopoulos; Frederick W Alt; Katrin F Chua; Danica Chen
Journal:  Cell Rep       Date:  2013-11-07       Impact factor: 9.423

10.  NAFLD prevalence differs among hispanic subgroups: the Multi-Ethnic Study of Atherosclerosis.

Authors:  Michael Wayne Fleischman; Matthew Budoff; Ifran Zeb; Dong Li; Temitope Foster
Journal:  World J Gastroenterol       Date:  2014-05-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.